Cure My Disease

Don't miss your cure!

 Log in / Sign up

Family support may curb obesity risk in children of mothers with gestational diabetes

NCT ID NCT07717515

Prevention Sponsor: Thai Binh University of Medicine and Pharmacy Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 21, 2026 · Last updated Jul 23, 2026 · Updated 2 times

Summary

This trial tests a family-focused program for women diagnosed with gestational diabetes in northern Vietnam. The program includes nutrition advice, physical activity guidance, breastfeeding support, and digital tools, delivered from pregnancy through two years after birth. The goal is to see if this approach increases exclusive breastfeeding and improves children's body composition, potentially reducing the risk of childhood obesity.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a family-based behavioral intervention including counseling, peer support, digital tools, and educational materials
What this could lead to
If successful, this program could help prevent childhood obesity and improve long-term health for mothers and children affected by gestational diabetes.
What could go wrong
This is a single trial in one region of Vietnam, so results may not apply elsewhere. The intervention is complex and relies on family participation, which may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 2,546 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Nov 2026

An estimate. Start dates often move.

Expected to finish

Aug 2030

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Confirmed GDM diagnosis in the current pregnancy according to WHO criteria and enrolled no longer than seven days after diagnosis. * Gestational age at enrolment ≤ 28+0 weeks of pregnancy. * Maternal age ≥18 years at consent. * Pregnancy with singleton gestation * Residence within the study catchment area. * Language proficiency sufficient to complete consent and study procedures in Vietnamese. * Capacity to provide informed consent and willingness to participate in all trial procedures, including randomisation Exclusion Criteria: * Pregestational diabetes (type 1 or type 2) diagnosed prior to this pregnancy. * Severe chronic medical conditions and chronic severe mental health conditions likely to interfere with participation, safety, or outcome assessment (e.g., advanced cardiac, renal, hepatic disease; active malignancy; severe uncontrolled endocrine disease other than GDM, schizophrenia, active psychosis). * Inability to provide informed consent . * Pregnant women with multiple gestations. * Pregnant women where it is biologically impossible for the woman to breastfeed, e.g., the woman has undergone bilateral mastectomy. * Any other condition that, in the judgment of the investigators, makes participation inappropriate or infeasible, e.g., surrogate mother.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GDM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Breast Feeding diabetes mellitus gestational diabetes Motor Activity Pediatric Obesity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GDM

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Thai Binh University of Medicine and Pharmacy

    Thái Bình, Hưng Yên Province, Vietnam

More trials for these conditions

Other studies related to the condition(s) this trial covers.